Hikma Pharmaceuticals Share Discussion Threads

[scepticalinvestor] 24/5/2022 07:57

It was prob time tbh

[blue59] 24/5/2022 07:46

Well at least they can treat themselves every time they shoot themselves in the foot.

[robertball] 24/5/2022 07:26

Not sure too. He was good at Teva and Hikma price rose after he joined.

[scepticalinvestor] 24/5/2022 07:23

Not sure abt that, but will be adding a shot load if so

[sza2002] 24/5/2022 07:22

Probably 1584 at the open?

[scepticalinvestor] 24/5/2022 07:10

Good riddance, markets will like that i think

[blue59] 20/5/2022 16:27

That’s the 5th time you’ve repeated it! It doesn’t make it any more relevant!!!

[montyhedge] 20/5/2022 10:33

I'll go with Barclays recent 2800p target, not your 1600p, lol.

[scepticalinvestor] 18/5/2022 14:55

And back to the 1600s...

[montyhedge] 18/5/2022 09:23

Barclays have a BUY target 2800p, I go with them.

[scepticalinvestor] 17/5/2022 11:50

I reckon this is being played by short day traders - look at the spikes they set up

[mjneish] 16/5/2022 18:48

Oh yes quite right. I missed that somehow.

[dartboard1] 16/5/2022 17:18

There was an update

[mjneish] 14/5/2022 14:33

Where is this from? I was going from the recent trading statement.

"We continue to expect full year Generics revenue growth in the range 8% to 10% and core operating margin in the range of 24% to 25%, assuming a mid-year launch of sodium oxybate. We expect Generics revenue will be weighted towards the second half of the year."

[dartboard1] 14/5/2022 12:17

Not really. PY generics revenue was 820, and forecast is 710-750. PY generics margin was 24 and forecast is 20. So agree generics is definitely not looking good this year, but there's two other divisions doing well, so group as a while is not in terminal decline as skeptical suggests. Zoom out and have a look at the growth over 5 years (not share price growth of course) and it's a good story

[mjneish] 14/5/2022 11:12

It isn't falling revenue in generics either, just slower growth. And they flagged revenue being weighted towards the end of the year.

[dartboard1] 14/5/2022 09:12

Falling revs in generics this year.. not the other divisions... Or the group overall

[scepticalinvestor] 13/5/2022 14:16

Another 30% drop coming.....

[scepticalinvestor] 13/5/2022 14:10

Huge amounts of stock being dumped. Might be time to cut losses...

[scepticalinvestor] 13/5/2022 09:54

Yes, bargepole territory now...not even a qtr of a billion share buyback helps this

[montyhedge] 12/5/2022 18:44

Lol, you would only lose it on some other share.